The journal of allergy and clinical immunology. In practiceHumansPeanut HypersensitivityDesensitizationImmunologicMale
Peanut Oral Immunotherapy Using 30 and 300 mg Maintenance Doses.
Julia E M Upton, Diana Toscano-Rivero, Danbing Ke, Alireza Berenjy, Duncan Lejtenyi, Liane Beaudette, Xiaojun Yin, Carmen Hong Li, Lucy Y Duan, Casey G Cohen, Vy Kim, Shireen Marzouk, Eyal Grunebaum, Christine T McCusker, Bruce Mazer
Published: 202610.1016/j.jaip.2025.10.007
Abstract
BACKGROUND: The lowest dose of peanut oral immunotherapy (P-OIT) has not been determined. OBJECTIVE: To evaluate whether very low-dose oral immunotherapy (30 mg) may safely and effectively increase tolerated doses and induce immunologic changes. METH…
Preview only. Read the full abstract at the source